Task: Answer the multiple-choice question.
Question: Which drug exhibits a 1.813% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) Nc1c(-c2ccc(Cl)cc2)cnc2ncnn12
b.) Cc1ccc(/C=N/OC(=O)c2nn(C)cc2Cl)cc1
Answer: b. Cc1ccc(/C=N/OC(=O)c2nn(C)cc2Cl)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(/C=N/OC(=O)c2nn(C)cc2Cl)cc1
Cc1ccc(/C=N/OC(=O)c2nn(C)cc2Cl)cc1
[(E)-(4-methylphenyl)methylideneamino] 4-chloro-1-methylpyrazole-3-carboxylate